Endothelial injury in COVID-19 and septic patients
Copyright © 2021 Elsevier Inc. All rights reserved..
Systemic inflammatory response, as observed in sepsis and severe COVID-19, may lead to endothelial damage. Therefore, we aim to compare the extent of endothelial injury and its relationship to inflammation in both diseases. We included patients diagnosed with sepsis (SEPSIS group, n = 21), mild COVID-19 (MILD group, n = 31), and severe COVID-19 (SEVERE group, n = 24). Clinical and routine laboratory data were obtained, circulating cytokines (INF-γ, TNF-α, and IL-10) and endothelial injury markers (E-Selectin, Tissue Factor (TF) and von Willebrand factor (vWF)) were measured. Compared to the SEPSIS group, patients with severe COVID-19 present similar clinical and laboratory data, except for lower circulating IL-10 and E-Selectin levels. Compared to the MILD group, patients in the SEVERE group showed higher levels of TNF-α, IL-10, and TF. There was no clear relationship between cytokines and endothelial injury markers among the three studied groups; however, in SEVERE COVID-19 patients, there is a positive relationship between INF-γ with TF and a negative relationship between IL-10 and vWF. In conclusion, COVID-19 and septic patients have a similar pattern of cytokines and endothelial dysfunction markers. These findings highlight the importance of endothelium dysfunction in COVID-19 and suggest that endothelium should be better evaluated as a therapeutic target for the disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:140 |
|---|---|
| Enthalten in: |
Microvascular research - 140(2022) vom: 30. März, Seite 104303 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hokama, Larissa Tami [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 04.02.2022 Date Revised 17.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mvr.2021.104303 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334511550 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334511550 | ||
| 003 | DE-627 | ||
| 005 | 20231225223838.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mvr.2021.104303 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1114.xml |
| 035 | |a (DE-627)NLM334511550 | ||
| 035 | |a (NLM)34914941 | ||
| 035 | |a (PII)S0026-2862(21)00173-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hokama, Larissa Tami |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endothelial injury in COVID-19 and septic patients |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.02.2022 | ||
| 500 | |a Date Revised 17.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a Systemic inflammatory response, as observed in sepsis and severe COVID-19, may lead to endothelial damage. Therefore, we aim to compare the extent of endothelial injury and its relationship to inflammation in both diseases. We included patients diagnosed with sepsis (SEPSIS group, n = 21), mild COVID-19 (MILD group, n = 31), and severe COVID-19 (SEVERE group, n = 24). Clinical and routine laboratory data were obtained, circulating cytokines (INF-γ, TNF-α, and IL-10) and endothelial injury markers (E-Selectin, Tissue Factor (TF) and von Willebrand factor (vWF)) were measured. Compared to the SEPSIS group, patients with severe COVID-19 present similar clinical and laboratory data, except for lower circulating IL-10 and E-Selectin levels. Compared to the MILD group, patients in the SEVERE group showed higher levels of TNF-α, IL-10, and TF. There was no clear relationship between cytokines and endothelial injury markers among the three studied groups; however, in SEVERE COVID-19 patients, there is a positive relationship between INF-γ with TF and a negative relationship between IL-10 and vWF. In conclusion, COVID-19 and septic patients have a similar pattern of cytokines and endothelial dysfunction markers. These findings highlight the importance of endothelium dysfunction in COVID-19 and suggest that endothelium should be better evaluated as a therapeutic target for the disease | ||
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Cytokines | |
| 650 | 4 | |a E-Selectin | |
| 650 | 4 | |a Systematic inflammation | |
| 650 | 4 | |a Tissue Factor | |
| 650 | 4 | |a von Willebrand Factor | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a E-Selectin |2 NLM | |
| 650 | 7 | |a IL10 protein, human |2 NLM | |
| 650 | 7 | |a SELE protein, human |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 650 | 7 | |a von Willebrand Factor |2 NLM | |
| 650 | 7 | |a Interleukin-10 |2 NLM | |
| 650 | 7 | |a 130068-27-8 |2 NLM | |
| 650 | 7 | |a Interferon-gamma |2 NLM | |
| 650 | 7 | |a 82115-62-6 |2 NLM | |
| 650 | 7 | |a C-Reactive Protein |2 NLM | |
| 650 | 7 | |a 9007-41-4 |2 NLM | |
| 650 | 7 | |a Thromboplastin |2 NLM | |
| 650 | 7 | |a 9035-58-9 |2 NLM | |
| 700 | 1 | |a Veiga, Alicia Dudy Müller |e verfasserin |4 aut | |
| 700 | 1 | |a Menezes, Maria Clara Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Sardinha Pinto, Agnes Araujo |e verfasserin |4 aut | |
| 700 | 1 | |a de Lima, Thais Martins |e verfasserin |4 aut | |
| 700 | 1 | |a Ariga, Suely Kunimi Kubo |e verfasserin |4 aut | |
| 700 | 1 | |a Barbeiro, Hermes Vieira |e verfasserin |4 aut | |
| 700 | 1 | |a Barbeiro, Denise Frediani |e verfasserin |4 aut | |
| 700 | 1 | |a de Lucena Moreira, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Stanzani, Gabriela |e verfasserin |4 aut | |
| 700 | 1 | |a Brandao, Rodrigo Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Marchini, Julio Flavio |e verfasserin |4 aut | |
| 700 | 1 | |a Alencar, Julio Cesar |e verfasserin |4 aut | |
| 700 | 1 | |a Marino, Lucas Oliveira |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez, Luz Marina |e verfasserin |4 aut | |
| 700 | 0 | |a Emergency USP COVID-19 Group |e verfasserin |4 aut | |
| 700 | 1 | |a Souza, Heraldo P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Microvascular research |d 1969 |g 140(2022) vom: 30. März, Seite 104303 |w (DE-627)NLM000033715 |x 1095-9319 |7 nnns |
| 773 | 1 | 8 | |g volume:140 |g year:2022 |g day:30 |g month:03 |g pages:104303 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mvr.2021.104303 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 140 |j 2022 |b 30 |c 03 |h 104303 | ||